Interesting facts
Interesting Facts About 1-(4-chlorophenyl)-2-[3-(5,6-dihydrobenzo[b][1]benzazepin-11-yl)propyl-methyl-amino]ethanone
This compound, with its intricate structure and potential applications in medicinal chemistry, provides a fascinating glimpse into the world of pharmaceuticals. Here are some key points to consider:
- Complex Structure: The structure of this compound illustrates a blend of various chemical functionalities, including an aromatic ring system, a carbonyl group, and a secondary amine.
- Potential Therapeutic Applications: Compounds similar to this one often serve as precursor molecules in the development of medications aimed at treating neurological or psychological conditions, reflecting the importance of structure-activity relationships in drug design.
- Synthetic Interest: The synthetic pathways leading to such complex molecules are of particular interest in organic chemistry. Researchers often explore various methods to enhance yield and selectivity during synthesis.
- Chlorine Substitution: The presence of a chlorine atom adds intriguing properties to the compound, often enhancing biological activity while also affecting lipophilicity and overall pharmacokinetics.
- Stereochemistry and Activity: The spatial arrangement of atoms in this compound may significantly influence its biological activity. With proper stereochemical analysis, scientists can tailor compounds to achieve desired therapeutic effects.
In summation, this compound is not just a series of atoms and bonds; it represents a gateway to understanding complex biological interactions and the synthesis of pharmaceuticals. As researchers continue to explore its properties, this compound may unlock new possibilities in the realm of medicinal chemistry.
Synonyms
LOFEPRAMINE
23047-25-8
Lopramine
Amplit
Leo 640
Lofepramina
Lofepraminum
Gamanil
Lomont
Lofepramine [INN:BAN]
Lofepraminum [INN-Latin]
Lofepramina [INN-Spanish]
OCA4JT7PAW
UNII-OCA4JT7PAW
HSDB 7184
4'-Chlor-2-((3-(10,11-dihydro-5H-dibenz(b,f)azepin-5-yl)propyl)methylamino)acetophenon
EINECS 245-396-8
Lofepramine (INN)
DB 2182
Ethanone, 1-(4-chlorophenyl)-2-[[3-(10,11-dihydro-5H-dibenz[b,f]azepin-5-yl)propyl]methylamino]-
Gamanil (Salt/Mix)
Gamonil (Salt/Mix)
Timelit (Salt/Mix)
Tymelyt (Salt/Mix)
CHEBI:47782
LOFEPRAMINE [MI]
Ethanone, 1-(4-chlorophenyl)-2-((3-(10,11-dihydro-5H-dibenz(b,f)azepin-5-yl)propyl)methylamino)-
LOFEPRAMINE [INN]
LOFEPRAMINE [JAN]
LOFEPRAMINE [HSDB]
LOFEPRAMINE [WHO-DD]
1-(4-chlorophenyl)-2-[3-(5,6-dihydrobenzo[b][1]benzazepin-11-yl)propyl-methylamino]ethanone
DTXSID2023220
Lofepramin hydrochloride (Salt/Mix)
Acetophenone, 4'-chloro-2-((3-(10,11-dihydro-5H-dibenz(b,f)azepin5-yl)propyl)methylamino)-
1-(4-Chlorophenyl)-2-((3-(10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)propyl)(methyl)amino)ethan-1-one
1-(4-chlorophenyl)-2-{[3-(10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)propyl](methyl)amino}ethanone
Amplit (TN)
Lofepraminum (INN-Latin)
Lofepramina (INN-Spanish)
4'-chloro-2-((3-(10,11-dihydro-5H-dibenz(b,f)azepin5-yl)propyl)methylamino)acetophenone
4'-Chloro-2-[[3-(10,11-dihydro-5H-dibenz[b,f]azepin-5-yl)propyl]methylamino]acetophenone
1-(4-chlorophenyl)-2-{[3-(10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)propyl]methylamino}ethanone
4'-CHLORO-2-((3-(10,11-DIHYDRO-5H-DIBENZ(B,F)AZEPIN-5-YL)PROPYL)METHYLAMINO)ACETOPHENONE
N-Methyl-N(4-chlorobenzoylmethyl)-3-(10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)propylamine hydrochloride
NCGC00166397-02
1-(4-chlorophenyl)-2-((3-(10,11-dihydro-5H-dibenzo(b,f)azepin-5-yl)propyl)(methyl)amino)ethanone
1-(4-chlorophenyl)-2-((3-(10,11-dihydro-5H-dibenzo(b,f)azepin-5-yl)propyl)methylamino)ethanone
1-(4-chlorophenyl)-2-(3-(5,6-dihydrobenzo(b)(1)benzazepin-11-yl)propyl-methylamino)ethanone
N-Methyl-N(4-chlorobenzoylmethyl)-3-(10,11-dihydro-5H-dibenzo(b,f)azepin-5-yl)propylamine hydrochloride
4'-Chloro-2-
Gamanil (United Kingdom)
1-(4-Chlorophenyl)-2-
1-(4-Chlorophenyl)-2-[[3-(10,11-dihydro-5H-dibenz[b,f]azepin-5-yl)propyl]methylamino]ethanone
SCHEMBL35028
CHEMBL87708
DTXCID303220
GTPL7551
Lofepramine - Bio-X trade mark
BDBM82437
N06AA07
HMS3269O19
HMS3413F21
HMS3677F21
HMS3715L16
NSC_3947
AKOS024457158
CCG-221257
DB13411
FL24917
NCGC00166397-01
NCGC00166397-03
BL164630
DA-54990
HY-12390
US8629135, SW-06
CAS_23047-25-8
CS-0011244
NS00004691
D08140
G12703
AB00698521-05
L000944
Q368941
BRD-K82147103-001-02-7
BRD-K82147103-003-05-6
Z2681890859
N-methyl-N-(4-chlorobenzoylmethyl)-3-(10,11-dihydro-5H-dibenzo
1-(4-Chlorophenyl)-2-[[3-(10,11-dihydro-5H-dibenz[b,f]azepin-5-yl)propyl]methylamino]ethanone;4'-Chloro-2-[[3-(10,11-dihydro-5H-dibe nz[b,f]azepin-5-yl)propyl-methylamino]acetophenone
1-(4-Chlorophenyl)-2-[[3-(10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)propyl](methyl)amino]ethanone #
245-396-8
Solubility of 1-(4-chlorophenyl)-2-[3-(5,6-dihydrobenzo[b][1]benzazepin-11-yl)propyl-methyl-amino]ethanone
The solubility of the compound with the formula C14H22ClN3O can be influenced by several key factors. Understanding these can shed light on its behavior in various solvents:
In summary, while the solubility of 1-(4-chlorophenyl)-2-[3-(5,6-dihydrobenzo[b][1]benzazepin-11-yl)propyl-methyl-amino]ethanone is likely to be moderate in polar solvents, specific experimental data is essential for precise characterization. Always consider how the molecular structure interplays with the solvent environment to make informed predictions about solubility.